CheckMyRecalls

Lupin Pharmaceuticals Inc. recalls Sertraline Hydrochloride Tablets USP

Published
17 Dec 2025
Units affected
52,128 bottles
Agency
FDA
Country
United States

The hazard

Defective container - seal not adhering to bottles

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Sertraline Hydrochloride Tablets USP, 100 mg, 90 Tablets bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc., Naples, FL 34108, NDC 68180-353-09.

Brand / company
Lupin Pharmaceuticals Inc.
Codes / lots
Lot # QB00865, exp. date Feb 2028
Distribution
Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 17 Dec 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.